A detailed history of Allworth Financial LP transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Allworth Financial LP holds 6,360 shares of TAK stock, worth $88,086. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,360
Previous 7,355 13.53%
Holding current value
$88,086
Previous $95,000 5.26%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$13.0 - $15.08 $12,935 - $15,004
-995 Reduced 13.53%
6,360 $90,000
Q2 2024

Jul 23, 2024

BUY
$12.6 - $13.67 $12,385 - $13,437
983 Added 15.43%
7,355 $95,000
Q1 2024

Apr 25, 2024

BUY
$13.89 - $15.04 $513 - $556
37 Added 0.58%
6,372 $88,000
Q4 2023

Jan 24, 2024

BUY
$13.36 - $15.43 $2,030 - $2,345
152 Added 2.46%
6,335 $90,000
Q3 2023

Oct 31, 2023

BUY
$15.03 - $16.32 $48,937 - $53,137
3,256 Added 111.24%
6,183 $95,000
Q2 2023

Jul 18, 2023

SELL
$15.57 - $17.11 $2,024 - $2,224
-130 Reduced 4.25%
2,927 $45,000
Q1 2023

Apr 18, 2023

BUY
$15.28 - $16.48 $4,064 - $4,383
266 Added 9.53%
3,057 $50,000
Q4 2022

Jan 13, 2023

SELL
$12.42 - $15.62 $993 - $1,249
-80 Reduced 2.79%
2,791 $0
Q3 2022

Oct 18, 2022

BUY
$12.8 - $28.65 $29,888 - $66,897
2,335 Added 435.63%
2,871 $37,000
Q2 2022

Jul 13, 2022

BUY
$13.12 - $15.03 $6,113 - $7,003
466 Added 665.71%
536 $8,000
Q3 2020

Nov 03, 2020

SELL
$17.1 - $19.19 $2,154 - $2,417
-126 Reduced 64.29%
70 $1,000
Q2 2020

Jul 24, 2020

BUY
$14.59 - $19.5 $1,838 - $2,457
126 Added 180.0%
196 $4,000
Q1 2019

May 07, 2019

BUY
$16.7 - $21.52 $1,169 - $1,506
70 New
70 $1,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.